Ledger.Open graph →
SEC Form D · filed November 24, 2023

Octave Bioscience Inc

Offering
$7.0M
Sold
$7.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
MENLO PARK, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Daniel Gwak · San Diego, CADirectorChristopher Mclaughlin · Chicago, ILExecWilliam Hagstrom · MENLO PARK, CAExec · DirectorBrook Byers · MENLO PARK, CADirectorAndrea Jackson · MENLO PARK, CADirectorJonathan D. Herpy · Wilmington, DEDirectorDana Emberton · Greenville, SCDirectorMelinda Thomas · MENLO PARK, CAExecLeo Polovets · San Francisco, CADirectorAngela J. Brau · Provo, UTDirectorA. Grant Heidrich Iii · MENLO PARK, CADirectorGeorge Scangos · MENLO PARK, CADirectorJonathan Landsverk · Greenville, SCDirectorClifford Pollard · Oakdale, CADirectorDerrin J. Hill · Provo, UTDirectorChad Byers · San Francisco, CADirectorTuan Ho · San Francisco, CADirectorPeter Levine · San Diego, CADirectorJack Abraham · San Francisco, CAExecBrandon Tseng · San Diego, CADirectorThomas Hawes · MENLO PARK, CADirectorMichael Pellini · MENLO PARK, CADirectorBobby Marhamat · San Francisco, CAExec · DirectorKenton C. Leo · Lone Tree, COExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗